Lisamaura Tulimiero
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
LKB1 Dysregulation in Duchenne Muscular Dystrophy Models: Disease Specificity and Epigenetic Control by HDAC Inhibitors.
Journal: Annals of the New York Academy of Sciences
Published: November 21, 2025
Diaphragm-specific effects of L-citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy.
Journal: British journal of pharmacology
Published: October 30, 2025
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 30, 2025
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models.
Journal: Scientific reports
Published: April 22, 2025
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse.
Journal: PloS one
Published: May 29, 2024
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy.
Journal: Frontiers in immunology
Published: December 09, 2022
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model.
Journal: Disease models & mechanisms
Published: October 05, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026